James J Driscoll

12PUBLICATIONS
22CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunityMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 20, 2026
Cost-Effectiveness of Maintaining Higher Stem-Cell Collection Thresholds in the Chimeric Antigen Receptor T-Cell Era for Multiple Myeloma.

Ehsan Malek, Brian Betts, Megan Herr

|Aug 30, 2024
Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity.

Priyanka S Rana, James J Ignatz-Hoover, Chunna Guo

|Aug 27, 2024
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial.

Ehsan Malek, Priyanka S Rana, Muthulekha Swamydas

|May 15, 2024
HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity.

Priyanka S Rana, James J Ignatz-Hoover, Byung-Gyu Kim

|Dec 09, 2023
Targeting Proteasomes and the MHC Class I Antigen Presentation Machinery to Treat Cancer, Infections and Age-Related Diseases.

Priyanka S Rana, James J Ignatz-Hoover, James J Driscoll

|Sep 22, 2023
Machine Learning Approach for Rapid, Accurate Point-of-Care Prediction of M-Spike Values in Multiple Myeloma.

Ehsan Malek, Gi-Ming Wang, Curtis Tatsuoka

Pageof 2

Frequent Collaborators

4 joint publications

Ehsan Malek

4 joint publications

Priyanka S Rana

3 joint publications

James J Ignatz-Hoover

2 joint publications

Drew J Adams